Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Rh Blood Group01:19

Rh Blood Group

4.6K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.6K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

71
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
71
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
6.2K
Diphtheria01:28

Diphtheria

146
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
146
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

991
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
991

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same author

Vitamin A and body weight status do not impact humoral immunity against measles, mumps or rubella in individuals 4 to 18 years old: a cross-sectional cohort study in India.

Vaccine·2026
Same author

Cytomegalovirus serostatus and plasma MCP-1 levels are associated with antibody response to seasonal influenza vaccine across age and sex.

medRxiv : the preprint server for health sciences·2026
Same author

Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine.

Vaccine·2026
Same author

Seroprevalence of mumps and rubella antibodies among Indian children: evidence of a mumps immunity gap.

Vaccine·2026
Same author

COVID-19 vaccine policy: a response and way forward.

Vaccine·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Apr 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K

La rubéola es la rubéola.

Nathaniel Lambert1, Peter Strebel2, Walter Orenstein3

  • 1Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.

Lancet (London, England)
|January 12, 2015
PubMed
Resumen
Este resumen es generado por máquina.

El virus de la rubéola sigue siendo una amenaza global, causando el síndrome de rubéola congénita. Los programas de vacunación contra la rubéola son clave para el control, pero los factores genéticos influyen en las respuestas inmunes a la vacuna.

Más Videos Relacionados

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.6K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.6K

Videos de Experimentos Relacionados

Last Updated: Apr 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.7K
Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test
08:58

Enhanced Rabies Surveillance Using a Direct Rapid Immunohistochemical Test

Published on: April 30, 2019

9.6K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.6K

Área de la Ciencia:

  • Inmunología Inmunología.
  • Vacunología La vacunología.
  • Salud Pública La salud pública.

Sus antecedentes:

  • El virus de la rubéola continúa representando un riesgo significativo para la salud mundial, con aproximadamente 100.000 casos estimados de síndrome de rubéola congénita anualmente.
  • Si bien las vacunas que contienen rubéola son altamente efectivas, los programas de vacunación incompletos contribuyen a la transmisión continua de la enfermedad, como lo destacan los brotes recientes.

Objetivo del estudio:

  • Revisar las estrategias de control, eliminación y erradicación de la rubéola.
  • Presentar nuevos métodos de diagnóstico de laboratorio para la rubéola.
  • Para explorar la inmunogenética de la vacuna que contiene rubéola y las variaciones de la respuesta inmune individual.

Principales métodos:

  • Revisión de las políticas de control de la rubéola y el diagnóstico de laboratorio.
  • Análisis de los datos inmunogenéticos relacionados con las vacunas que contienen rubéola.
  • Investigación de la variabilidad interindividual en las respuestas inmunes.

Principales resultados:

  • La transmisión endémica de la rubéola se ha eliminado en las Américas desde 2009.
  • La vacunación incompleta conduce a continuos brotes de rubéola en todo el mundo.
  • La evidencia emergente vincula las variaciones genéticas (haplotipos, SNPs) a las respuestas inmunes a las vacunas contra la rubéola.

Conclusiones:

  • La vacunación contra la rubéola es crucial para el control de la enfermedad y los esfuerzos de eliminación.
  • Comprender la inmunogenética de las vacunas es vital para optimizar la eficacia de la vacuna contra la rubéola.
  • La investigación adicional sobre las asociaciones genéticas puede informar estrategias de vacunación personalizadas.